![](/img/cover-not-exists.png)
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
Gaziano, J Michael, Brotons, Carlos, Coppolecchia, Rosa, Cricelli, Claudio, Darius, Harald, Gorelick, Philip B, Howard, George, Pearson, Thomas A, Rothwell, Peter M, Ruilope, Luis Miguel, Tendera, MicLanguage:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)31924-X
Date:
August, 2018
File:
PDF, 464 KB
english, 2018